Fresenius stock at EUR 44.81 ahead of the Xetra open: little changed
Published on 10/20/2026 at 09:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and calendar
- Fresenius operates healthcare businesses spanning hospital services, medicines and infusion solutions.
- The investor-relations calendar lists November 4, 2026, for the third-quarter 2026 telephone conference.
- Fresenius stock trades pre-market at EUR 44.81 at 8:58 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.22 percent below the Xetra close of October 19, 2026.
Fresenius stock is little changed pre-market on October 20, 2026: at 8:58 a.m. CEST, it stood at EUR 44.81 at Lang & Schwarz, 0.22 percent below the Xetra close of October 19, 2026 (EUR 44.91).
Ahead of the Xetra open
The move amounts to minus EUR 0.10 compared with the previous Xetra session. The bid-ask spread remains below the threshold for inclusion in this report. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Fresenius stock.
Business and the day ahead
Fresenius operates healthcare businesses spanning hospital services, medicines and infusion solutions. The issuer's investor-relations page identifies Helios and Fresenius Kabi among its operating businesses. It lists November 4, 2026, for the third-quarter 2026 telephone conference. The date and company information are available from Fresenius Investor Relations. Market context: Market report DAX.
